1. Liver grafts from anti-hepatitis B core positive donors: A systematic review 
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Journal of Hepatology 
Volume 52, Issue 2, Pages (February 2010)
DOI: /j.jhep
Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
Risk ofde novohepatitis B virus (HBV) infection in HBsAg-negative recipients who received liver grafts from anti-HBc positive donors and no HBV prophylaxis after liver transplantation (LT) in relation to their HBV serological status before transplant.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
Risk ofde novohepatitis B virus (HBV) infection in HBsAg-negative recipients of liver grafts from anti-HBc positive donors in relation to their pre-transplant HBV serological status and the use of HBV prophylaxis after liver transplantation (LT).
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

4. Fig. 3
Risk ofde novohepatitis B virus (HBV) infection in HBsAg-negative recipients who received liver grafts from anti-HBc positive donors and HBV prophylaxis after liver transplantation (LT) in relation to their pre-transplant HBV serological status and the type of post-transplant HBV prophylaxis.HBIG, hepatitis B immunoglobulin; LAM, lamivudine.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

5. Fig. 4
Proposed algorithm for allocation and management of anti-HBc positive liver grafts. Such grafts should be first offered to HBsAg positive, then to anti-HBc and/or anti-HBs positive and lastly to HBV naive (both anti-HBc and anti-HBs negative) recipients. LT, liver transplantation; HBIG, hepatitis B immunoglobulin; LAM, lamivudine.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2009 European Association for the Study of the Liver Terms and Conditions